Mira Pharmaceuticals (MIRA) Assets Average (2023 - 2025)

Mira Pharmaceuticals has disclosed Assets Average across 3 years of filings, most recently posting $9.4 million for Q4 2025.

• Assets Average for Q4 2025 came in at $9.4 million, up 160.47% year-over-year; the trailing twelve-month figure through Dec 2025 was $9.4 million (up 160.47% YoY), and the FY2025 annual result was $7.0 million, up 78.43% from the prior year.
• Assets Average came in at $9.4 million for Q4 2025 at Mira Pharmaceuticals, up from $4.3 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $9.4 million in Q4 2025 to a low of $1.1 million in Q2 2025.
• The 3-year median for Assets Average is $4.3 million (2024), against an average of $4.8 million.
• Peak annual rise in Assets Average reached 160.47% in 2025, while the deepest fall reached 50.54% in 2025.
• Mira Pharmaceuticals' Assets Average stood at $7.0 million in 2023, then plunged by 48.46% to $3.6 million in 2024, then surged by 160.47% to $9.4 million in 2025.
• The last three Assets Average figures came in at $9.4 million (Q4 2025), $4.3 million (Q3 2025), and $1.1 million (Q2 2025), per Business Quant data.